Time from diagnosis to initial treatment and survival in non-metastatic oesophago-gastric cancer: a systematic review
European Journal of Surgical Oncology · 2027-01 · 53 (1) · 112362
DOI: 10.1016/j.ejso.2026.112362 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Surgical Oncology, 2027-01. Verfasst von O O'Connor und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Audit Collaborating Centre, Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK; Department of Health Servi…. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Timely initiation of treatment is a key principle in cancer care but can be difficult for oesophago-gastric (OG) cancer services due to the complex staging pathway. This study reviewed the evidence on the impact of the diagnostic-to-treatment interval (DTI) on survival for OG cancer patients. METHODS: A systematic review of observational studies examining DTI and overall survival (OS) in oesophageal and gastric cancer was undertaken. Given substantial heterogeneity in interval definitions, exposure modelling, and analytical approaches, meta-analysis was not considered methodologically appropriate; therefore, a structured narrative synthesis was performed, focusing on threshold effects across the DTI distribution. RESULTS: Twenty studies were identified (12 evaluated gastric cancer; 8 oesophageal). Sample sizes ranged from 103 to 12,764 patients. DTIs of approximately 30-90 days were not consistently associated with worse overall survival. Longer intervals, typically beyond 90 days, were more frequently associated with poorer outcomes, although findings were inconsistent. All studies were at moderate or serious risk of bias, and selection of patients who ultimately received treatment may have attenuated associations at longer intervals. Poorer outcomes at shorter DTIs were also observed, consistent with clinical prioritisation and the 'waiting-time paradox'. CONCLUSION: The current evidence base contains heterogeneous results that are susceptible to bias. Observational studies did not demonstrate a consistent association between DTIs of approximately 30-90 days and worse overall survival. Some studies suggested poorer outcomes beyond approximately 90 days, although findings were inconsistent, and the current evidence is insufficient to define a clinically safe DTI threshold.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Cancer Audit Collaborating Centre, Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicin…
- National Cancer Audit Collaborating Centre, Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK; Guy's & St Thomas' Oesophago-Gastric Centre, London, UK.
- National Cancer Audit Collaborating Centre, Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK.
- Velindre Hospital, Cardiff, UK.
- Guy's & St Thomas' Oesophago-Gastric Centre, London, UK.
- Department of Gastroenterology, Sandwell General Hospital, West Bromwich, UK.
Zitieren
APA
O'Connor, O., Epton, S., McDonell, A., Darley, K., Crosby, T., Thomas, B., Gossage, J., Trudgill, N., Cromwell, D. A., & Park, M. H. (2027). Time from diagnosis to initial treatment and survival in non-metastatic oesophago-gastric cancer: a systematic review. European Journal of Surgical Oncology, 53(1), 112362. https://doi.org/10.1016/j.ejso.2026.112362
Vancouver
O'Connor O, Epton S, McDonell A, Darley K, Crosby T, Thomas B, et al. Time from diagnosis to initial treatment and survival in non-metastatic oesophago-gastric cancer: a systematic review. European Journal of Surgical Oncology. 2027;53(1):112362. doi:10.1016/j.ejso.2026.112362
BibTeX
@article{OConnor2027,
author = {O'Connor, O and Epton, S and McDonell, A and Darley, K and Crosby, T and Thomas, B and Gossage, J and Trudgill, N and Cromwell, D A and Park, M H},
title = {Time from diagnosis to initial treatment and survival in non-metastatic oesophago-gastric cancer: a systematic review},
journal = {European Journal of Surgical Oncology},
year = {2027},
volume = {53},
number = {1},
pages = {112362},
doi = {10.1016/j.ejso.2026.112362}
}
EUVIMED